Starbucks Expert Pressed On Cancer Risk In Prop 65 Trial

Law360, Los Angeles (September 9, 2014, 10:05 PM EDT) -- A toxicologist called by Starbucks Corp. to defend it in a Proposition 65 bench trial aimed at having its coffee labeled as containing the carcinogen acrylamide conceded under cross-examination Tuesday that no other chemical in coffee has been proven to inhibit the carcinogenic properties of acrylamide.

Tuesday was the second day of the bench trial that will see Los Angeles Superior Court Judge Elihu M. Berle rule on Starbucks' three affirmative defenses to the suit brought by the Council for Education and Research on Toxics, which contends Starbucks' coffee contains enough acrylamide, a known carcinogen, to cause cancer in consumers. CERT...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!